U2Bio Co., Ltd. (KOSDAQ:221800)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,125.00
+25.00 (0.81%)
At close: Aug 14, 2025, 3:30 PM KST

U2Bio Revenue

U2Bio had revenue of 5.62B KRW in the quarter ending March 31, 2025, with 0.74% growth. This brings the company's revenue in the last twelve months to 25.08B, down -11.14% year-over-year. In the year 2024, U2Bio had annual revenue of 25.04B, down -18.68%.

Revenue (ttm)
25.08B
Revenue Growth
-11.14%
P/S Ratio
1.41
Revenue / Employee
n/a
Employees
n/a
Market Cap
35.27B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202425.04B-5.75B-18.68%
Dec 31, 202330.79B-38.22B-55.38%
Dec 31, 202269.01B58.01B527.29%
Dec 31, 201411.00B1.59B16.90%
Dec 31, 20139.41B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition